Global Peripheral Intravenous (IV) Catheter Market 2017-2021
About Peripheral Intravenous (IV) Catheter
The peripheral intravenous catheter (PIVC) is a small flexible tube inserted into a peripheral vein to deliver medicines and nutritional supplements. It is also used to collect blood samples for diagnostic purpose. The peripheral intravenous (IV) catheters are of two types, namely, short peripheral intravenous catheters (PIVCs) and integrated/closed catheters (PIVCs). Short PIVCs are further segmented into ported short PIVCs and non-ported short PIVCs.
Technavio’s analysts forecast the global peripheral intravenous (IV) catheter market to grow at a CAGR of 6.73% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global peripheral intravenous (IV) catheter market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Peripheral Intravenous (IV) Catheter Market 2017-2021
Technavio recognizes the following companies as the key players in the global peripheral intravenous (IV) catheter market: B. Braun Melsungen, BD, C.R. Bard, Smiths Medical, and TERUMO CORPORATION.
Other Prominent Vendors in the market are: AngioDynamics, APEXMED International, Delta Med, EXELINT International, GaltNeedleTech, Global Medikit, Hospira, NIPRO Medical, RenovoRx, Retractable Technologies, Teleflex, Vigmed, and Vygon.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing popularity of integrated/closed PIVCs. The traditional PIVCs consist of a small catheter tubing on an open adapter to which an IV-administration set is connected manually. Hence, the insertion of this catheter predisposes the patient to risks of infection. Healthcare workers also face the risk of exposure in these types of catheters.”
According to the report, one driver in the market is increase in number of hospitalizations. The number of hospitalizations is increasing worldwide due to the growth of the world population and the rising prevalence of various acute and chronic diseases. In the US, the total number of inpatient hospitalizations increased by 15% from 31.7 million in 2000 to 36.5 million in 2012. According to the Centers for Disease Control and Prevention (CDC), in 2014, there were 141.4 million emergency department visits, resulting in 11.2 million hospital admissions and 1.8 million critical care unit admissions in the US. In 2014, about 20.0 million people visited physicians' offices with cancer as the primary diagnosis, 17.8 million people visited physicians' offices, and 3.9 million people visited hospital outpatient departments due to infectious and parasitic diseases in the US.
Further, the report states that one challenge in the market is complications associated with PIVCs. The PIVCs are found to be the most common source of bacteremia and fungemia. PIVCs predispose a patient to risks of local and systemic infections such as CR-BSIs, septic thrombophlebitis, endocarditis, and other metastatic infections that include lung abscess, brain abscess, osteomyelitis, and endophthalmitis. Infiltration, phlebitis, and dislodgement are the three most common mechanical complications associated with PIVCs. The incidence of thrombophlebitis and bacterial colonization of catheters increases if short PIVCs are used for more than 72 hours.
B. Braun Melsungen, BD, C.R. Bard, Smiths Medical, and TERUMO CORPORATION, AngioDynamics, APEXMED International, Delta Med, EXELINT International, GaltNeedleTech, Global Medikit, Hospira, NIPRO Medical, RenovoRx, Retractable Technologies, Teleflex, Vigmed, and Vygon.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook